propafenone , an anti-arrhythmic medication recently introduced in class lc , was tested in a multicentric open study including 3,687 patients ( mean age : 60 years ) , presenting a supra ventricular ( n = 2,146 , 59 p. cent ) , nodal ( n = 351 , 10 p. cent ) or ventricular ( n = 1,613 , 44 p. cent ) arrhythmia , in order to study its efficacy and tolerance .
C0033429
propafenone
C0003811
arrhythmia